0001203311-22-000057.txt : 20221019 0001203311-22-000057.hdr.sgml : 20221019 20221019191732 ACCESSION NUMBER: 0001203311-22-000057 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221017 FILED AS OF DATE: 20221019 DATE AS OF CHANGE: 20221019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DANSEY ROGER D CENTRAL INDEX KEY: 0001741836 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 221319500 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-10-17 0 0001060736 Seagen Inc. SGEN 0001741836 DANSEY ROGER D 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 Interim CEO & CMO Common Stock 2022-10-17 4 M 0 4607 77.45 A 102146 D Common Stock 2022-10-17 4 S 0 4607 135.0 D 97539 D Common Stock 2022-10-17 4 M 0 3189 76.86 A 100728 D Common Stock 2022-10-17 4 S 0 3189 135.0 D 97539 D Common Stock 2022-10-17 4 M 0 2204 65.11 A 99743 D Common Stock 2022-10-17 4 S 0 2204 135.0 D 97539 D Non-Qualified Stock Option (right to buy) 65.11 2022-10-17 4 M 0 2204 0.0 D 2028-06-15 Common Stock 2204 0 D Non-Qualified Stock Option (right to buy) 76.86 2022-10-17 4 M 0 3189 0.0 D 2028-08-30 Common Stock 3189 0 D Non-Qualified Stock Option (right to buy) 77.45 2022-10-17 4 M 0 4607 0.0 D 2028-09-07 Common Stock 4607 9403 D Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Options vested at a rate of 25% on 5/21/2019 and monthly thereafter until all the options were fully vested on 5/21/22. Options vested at a rate of 25% on 8/30/2019 and monthly thereafter until all the options were fully vested on 8/30/22. By: /s/ Jennifer Prosba For: Roger Dansey 2022-10-19